VersaWrap Nerve Protector Receives 510(k) Clearance Reports Alafair Biosciences

September 24, 2020

The VersaWrap nerve protector received 510(k) clearance from the FDA. Alafair Biosciences announced the news today. Similar to VersaWrap® Tendon Protector indicated for tendon.

VersaWrap Nerve Protector is an ultrathin, sutureless, bioresorbable hydrogel implant ideally suited for covering and protecting peripheral nerves. By forming a permeable, gelatinous layer on or around the peripheral nerve, VersaWrap® provides a non-constricting interface between nerve and surrounding tissues during healing.

“VersaWrap is an exciting new product. We’ve been searching for something like this, a device that is pliable, that improves gliding, and that bioresorbs, to address adhesions,” stated Dr. Harvey Chim, MD, a plastic surgeon in Gainesville, FL. “Given the presence of hyaluronic acid in VersaWrap, the technology and its mechanism of action in tendon and peripheral nerve procedures makes sense. I’ve seen it work well in a variety of cases where scarring was a concern.” Dr. Chim has been using VersaWrap Tendon Protector for several years. “I use VersaWrap because my patients have better clinical outcomes.”

“We are pleased to have received 510(k) clearance for VersaWrap and believe that we will see rapid surgeon adoption given the unique characteristics of our product,” said Greg Brophy, CEO of Alafair. “Our patented hydrogel technology has diverse applications in the medical device and regenerative medicine segments, and the extension of our product portfolio to include peripheral nerve procedures is a substantial milestone for our organization.”

VersaWrap® is the second product in the VersaWrap® family of products to receive 510(k) clearance and is indicated for the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue. Alafair anticipates additional 510(k) filings as it seeks to expand the clinical applications for the use of its hydrogel technology.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy